RC
0000-0001-5125-6485 About
PhD student at the Department of Medical Oncology, AIIMS, New Delhi, dedicated to unraveling the intricate molecular mechanisms behind Gynaecological Cancers. Focused on investigating the oncogenic potential of Deubiquitinating Enzymes (DUBs) and aiming to enhance the understanding of cancer progression and inform novel therapeutic strategies. Passionate about connecting with fellow researchers, and industry professionals. Open to discussing ideas, and opportunities.
Employment
Employment history is unavailable.
Education
-
All-India Institute of Medical Sciences PhD Student2020 - 2025
-
Jamia Millia Islamia MS in Biochemistry2016 - 2018
-
Jamia Millia Islamia BS in Biosciences2013 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (7)
- Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments Save
- Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression Save
- Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics Save
- Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis Save
- Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cells Save
- Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial Save
- Histone Acetyltransferase MOF Orchestrates Outcomes at the Crossroad of Oncogenesis, DNA Damage Response, Proliferation, and Stem Cell Development Save